Literature DB >> 12712187

Cancer: Escape from inhibition.

Sara A Courtneidge.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12712187     DOI: 10.1038/422827a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Altered dynamics in Lck SH3 upon binding to the LBD1 domain of Herpesvirus saimiri Tip.

Authors:  David D Weis; Peter Kjellen; Bartholomew M Sefton; John R Engen
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 2.  The physiological role of Wnt pathway in normal development and cancer.

Authors:  Xiang Li; Maria A Ortiz; Leszek Kotula
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-29

3.  The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.

Authors:  Shugui Chen; Sébastien Brier; Thomas E Smithgall; John R Engen
Journal:  Protein Sci       Date:  2007-02-27       Impact factor: 6.725

4.  Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

Authors:  Sajjad Hossain; Patrycja M Dubielecka; Aleksander F Sikorski; Raymond B Birge; Leszek Kotula
Journal:  Genes Cancer       Date:  2012-05

5.  Abl N-terminal cap stabilization of SH3 domain dynamics.

Authors:  Shugui Chen; Teodora Pene Dumitrescu; Thomas E Smithgall; John R Engen
Journal:  Biochemistry       Date:  2008-05-02       Impact factor: 3.162

6.  Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.

Authors:  Xiaoling Xiong; Ping Cui; Sajjad Hossain; Rong Xu; Brian Warner; Xinhua Guo; Xiuli An; Asim K Debnath; David Cowburn; Leszek Kotula
Journal:  Biochim Biophys Acta       Date:  2008-02-15

7.  Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.

Authors:  Vidhi Malik; Navaneethan Radhakrishnan; Sunil C Kaul; Renu Wadhwa; Durai Sundar
Journal:  Biomolecules       Date:  2022-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.